Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) is listed in the pharmaceutical impurity collection under CAS 115-46-8. Its represented structure has formula C18H21NO and a calculated molecular weight of 267.37 g/mol.

2D chemical structure

O H N H

Chemical identity

Catalog name
Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)
Common name
Terfenadine Imp. I (EP)
Chemical name
Diphenyl(piperidin-4-yl)methanol (Azacyclonol)
CAS
115-46-8
SMILES
OC(c1ccccc1)(c1ccccc1)C1CCNCC1
InChI
InChI=1S/C18H21NO/c20-18(15-7-3-1-4-8-15,16-9-5-2-6-10-16)17-11-13-19-14-12-17/h1-10,17,19-20H,11-14H2
InChIKey
ZMISODWVFHHWNR-UHFFFAOYSA-N
Associated API
Terfenadine

Record ID: A6d327c92ca53

Computed properties

C18H21NO Molecular formula
267.372 g/molMolecular weight
267.1623 DaMonoisotopic exact mass
32.26 ŲTopological polar surface area
2.9221 Calculated LogP (Wildman–Crippen)
81.4765 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 5 10 15 20 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight267.37234.55
Calculated LogP (Wildman–Crippen)2.922160.27
Topological polar surface area32.2614.58
Hydrogen-bond acceptors215.92
Hydrogen-bond donors264.87
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC18H21NOdimensionless
Molecular weight267.372g/mol
Monoisotopic exact mass267.1623Da
Topological polar surface area32.26Ų
Calculated LogP (Wildman–Crippen)2.9221dimensionless
Molar refractivity (Wildman–Crippen)81.4765cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors2count
Rotatable bonds (strict)3count
Heavy atoms20count
Heteroatoms2count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings1count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area120.0164Ų
Valence electrons104count
Radical electrons0count
Bertz complexity492.3594index
Balaban J2.0699index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

Qualification and safety assessment of Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

Explore toxicological qualification of Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) and ICH M7 mutagenic impurity assessment of Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol) and acceptable intake and limit justification for Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Terfenadine Imp. I (EP): Diphenyl(piperidin-4-yl)methanol (Azacyclonol)

Explore Altox services and software through the Altox Pharma-Hub.